Wikipedia -WSS

Wikipedia

author：fashion 2025-09-29 22:53:17 - browse：1

Two people run on the sugar-phosphate backbone of DNA while holding base pairs — in the lab coverage from STAT — Adobe

LONDON — Widespread genetic testing as well as the development of cutting-edge, customized genetic therapies have opened the door to treating many more inherited conditions than previously possible. A few recent cases, in which bespoke medicines were created for children with exceedingly rare mutations, have raised hopes for furthering the approach.

Now, researchers and government agencies in the U.K. are trying to figure out the nitty-gritty to replicate those early one-off successes for as many patients as possible — what sort of preclinical testing a tailor-made treatment needs to go through before being used, what regulatory thresholds each treatment needs to clear, and how to pay for these therapies.

“A lot of the barriers are no longer scientific — we can make these drugs,” said Matthew Wood, a professor of pediatrics at the University of Oxford. “It’s more about, can we make them at a cost that is reasonable enough? And can we get the regulators to reduce the barriers to doing this so that when a patient shows up, you can actually make a drug quickly enough to benefit that patient, rather than it costing huge amounts of money and taking two or three years to do it?”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： Readout Newsletter: Beam, Prozac, "TechBio" and more

WSS

Pfizer is about to make a big push in cancer. Will investors listen?

Kale crackers and hibiscus tea: My five days on a 'fasting diet'

Color Health wants to make cancer screenings convenient

Study fuels hope CAR

Why getting cancer drugs just got harder for rural patients

Change Healthcare cyberattack shows risk of industry consolidation

hotspot

Wikipedia

hotspot

After affirmative action ruling, medical educators look to 'holistic review'

5 ways to address the shortage of health care workers

Bright Health sells Medicare Advantage business to Molina

Kenai launches with $82 million for Parkinson’s stem cell therapy

As demand for Covid shots wanes, Moderna seeks its next success

Study fuels hope CAR

Guidelines to prevent youth baseball injuries need more muscle

Medicare isn't yet testing food as medicine

Sports medicine is finally prioritizing gender equality

Medical device lobby: We're tired of waiting on Medicare coverage

leisure time

Color Health wants to make cancer screenings convenient

Why getting cancer drugs just got harder for rural patients

Biotech companies concerned about China biosecurity crackdown

FDA does about

Covid overtakes 1918 Spanish flu as deadliest disease in U.S. history

Medical device lobby: We're tired of waiting on Medicare coverage

explore

explore

hotspot

focus